Loading...

LXRX LEXICON PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

LXCN

LXRX

LEXICON PHARMACEUTICALS INC

(LXRX)

2025 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Filing with Quantitative Data

Filing with Quantitative Data

Filing with Quantitative Data

Capital Structure Change

Private Placement

Contract Renewal

Quantitative Data

External Links:

On July 3, 2025, Lexicon Pharmaceuticals received a 180-day extension from NASDAQ to comply with the $1 minimum bid price requirement for its stock, now transferring to the Nasdaq Capital Market effective July 7, 2025.

AI Assistant

LEXICON PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.